DadFinStart your free week
DadFin › Stocks › Financial Services › WTW

Willis Towers Watson Public Limite (WTW) stock score

Financial Services · Insurance Brokers · United Kingdom

$296.26 ▼ -0.54% today

35.5
Dad Score, out of 100
weak

Willis Towers Watson Public Limite (WTW) is a Insurance Brokers company in the Financial Services sector, listed in the United Kingdom. On DadFin's weekly run it scores 35.5 out of 100 on the Dad Score, a weak reading that places the business ahead of 35% of the 5,774 US and Canadian stocks DadFin fully scores. Inside Financial Services it ranks #911 of 1,228. Its strongest axes are quality, conviction and liquidity; its weakest are growth and price action.

Scores from the run of Oct 4, 2026. The Dad Score answers one question: how good is this business, measured against its own sector. How it is built →

The eight axes

Valuation
Average
Quality
Strong
Growth
Weak
Price action
Below average
Risk
Below average
Conviction
Strong
Liquidity
Strong
Macro
Strong

Each axis is ranked inside the stock's own sector. Subscribers see the percentile and every input behind each bar.

Key numbers

P/E (trailing)17.9×
P/E (forward)12.6×
Dividend yield0.64%
Return on capital14.1%
Operating margin17.6%
Revenue growth (YoY)-2.2%
FCF yield5.1%
Net debt / EBITDA1.93×
Piotroski F-Score6 / 9
52-week change-16.3%
Market cap$26.8B
Next earningsOct 29, 2026

What subscribers see on WTW

Start your free weekSubscriber? Open the full research →

Insurance Brokers peers

StockCompanyDad ScoreBandMarket cap
MRSHMarsh & McLennan Companies, Inc.97.7strong$81.2B
AJGArthur J. Gallagher & Co.55.2middling$58.0B
AONAon plc76.0good$57.2B
BROBrown & Brown, Inc.66.7middling$20.0B
ERIEErie Indemnity Company55.8middling$11.6B
RYANRyan Specialty Holdings, Inc.49.3middling$9.7B
ARXAccelerant Holdings9.1poor$4.3B
CRVLCorVel Corporation79.7good$3.8B

Prices from DadFin's live feed (refreshed about every 15 minutes in the session); scores from the weekly run of Oct 4, 2026. Fundamentals as reported in the latest filings. Research, not investment advice.